NDC 0121-0898-05 - Atovaquone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0121-0898
- Requested NDC
- 0121-0898-05
- Package NDCs from labels
- 0121-0898-05, 0121-0898-18, 0121-0898-42
- Manufacturer
- PAI Holdings, LLC dba PAI Pharma | PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma
- Effective date
- 2025-01-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atovaquone | PAI Holdings, LLC dba PAI Pharma | PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma | 2025-01-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-0898-05 | ML - Milliliter | 0121-0898 | b935a3b9-bb32-4911-804e-de6d7e0547b4 | 1 | 2021-06-02 |
| 0121-0898-18 | ML - Milliliter | 0121-0898 | a8595969-52aa-47a1-8cfb-0961f654034b | 1 | 2021-07-15 |
| 0121-0898-42 | ML - Milliliter | 0121-0898 | 9ee4e0de-319e-4820-aba1-2a4c6978f4d3 | 1 | 2021-06-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Unscented Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | Walgreen Co. | 41eadb4f-2ca5-42a1-e063-6294a90ab4e2 | 2026-03-04 | Warnings | LKG8494WBH |
| Atovaquone Oral Suspension | ATOVAQUONE | Kesin Pharma Corporation | 4a2e2c4b-85aa-9b30-e063-6294a90a7bd9 | 2026-02-06 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| Amalgam 6003 | AMALGAM | Professional Complementary Health Formulas | 1af74f69-a23a-45a2-a20e-92bf8b0ccb22 | 2026-01-08 | Warnings | TTV12P4NEE |
| Hepatatox | TRITICUM AESTIVUM, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, GLUTATHIONE, HEPAR SUIS, THYROIDINUM (SUIS), LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, ADRENOCORTICOTROPHIN, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, PHENYL BUTAZONE, PETROLEUM JELLY, PLUMBUM METALLICUM | BioActive Nutritional, Inc | a113a9f1-4792-41a5-8d1b-a6756f356e15 | 2025-12-18 | Warnings | LKG8494WBH |
| Atovaquone | ATOVAQUONE | Golden State Medical Supply, Inc. | ddbfe1a9-df9b-79b0-e053-2995a90acc9b | 2025-12-17 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| Atovaquone | ATOVAQUONE | Bionpharma Inc. | bff4f4fc-6307-f414-e053-2a95a90ac0de | 2025-12-04 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| Atovaquone | ATOVAQUONE | Chartwell Governmental & Specialty RX, LLC. | e6770b85-54f8-4969-af02-7d81586be761 | 2025-11-07 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| Zilactin Early Relief Cold Sore | BENZYL ALCOHOL | ASCENT CONSUMER PRODUCTS, INC | 42ef8bfa-c4d9-01cf-e063-6394a90ac88a | 2025-11-06 | Warnings | LKG8494WBH |
| Atovaquone | ATOVAQUONE | American Health Packaging | 1a8a43a2-bc26-4ee5-aa35-22a5477a7129 | 2025-10-17 | Warnings, Adverse reactions | ANDA210692 308429 Y883P1Z2LT |
| ATOVAQUONE | ATOVAQUONE | AvPAK | 4124ad97-f6b9-8afb-e063-6294a90ab970 | 2025-10-14 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| Atovaquone | ATOVAQUONE | ATLANTIC BIOLOGICALS CORP. | 40331de7-819e-5965-e063-6294a90ac91d | 2025-10-01 | Warnings, Adverse reactions | ANDA210692 308429 Y883P1Z2LT |
| Atovaquone | ATOVAQUONE | Kesin Pharma | 16b69156-e5de-c601-e063-6394a90afeae | 2025-09-15 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| ATOVAQUONE | ATOVAQUONE ORAL SUSPENSION | Major Pharmaceuticals | 73e2297e-7cda-4abf-9fb7-8c67cb5638a3 | 2025-08-13 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| dda9ce60-66d9-4d27-af71-2308040e8d60 | ba4bea2e-aeec-084d-e053-2a95a90a04d4 | 2025-08-11 | Warnings, Adverse reactions | ba4bea2e-aeec-084d-e053-2a95a90a04d4 | ||
| Atovaquone | ATOVAQUONE | ATLANTIC BIOLOGICALS CORP. | f99a8a0c-2b42-4da0-8f5a-e963fc619e8b | 2025-05-12 | Warnings, Adverse reactions | ANDA210692 308429 Y883P1Z2LT |
| Atovaquone | ATOVAQUONE | Abon Pharmaceuticals, LLC | 2d3715ed-6ddc-4c10-9d2c-9c80cb1dfd08 | 2025-05-12 | Warnings, Adverse reactions | 308429 Y883P1Z2LT |
| Atovaquone | ATOVAQUONE | Lohxa | ba3cad0d-cce9-424f-ba5c-557dba8bef12 | 2025-03-20 | Warnings, Adverse reactions | ANDA210692 308429 Y883P1Z2LT |
| Chemtox | TRITICUM AESTIVUM, BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, RHAMNUS PURSHIANA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), THYROIDINUM (SUIS), BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, | BioActive Nutritional, Inc. | a480e5f4-5f9e-4b23-b257-b0ac1ebfc115 | 2025-01-07 | Warnings | LKG8494WBH |
| Pain Relieving Cream Lidocaine | BENZYL ALCOHOL, LIDOCAINE HCI | Trifecta Pharmaceuticals USA LLC | 039a2036-54b2-cf28-e063-6294a90a8ce6 | 2024-12-31 | Warnings | LKG8494WBH |
| ITCH X | BENZYL ALCOHOL/PRAMOXINE HYDROCHLORIDE | BF ASCHER AND CO INC | 03c16d33-8f59-0184-e054-00144ff8d46c | 2024-12-05 | Warnings | LKG8494WBH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.